[1] Malek SN, Katumuluwa AI, Pasternack GR. Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteins[J].J Biol Chem,1990,265(22): 13400-13409. [2] Williams TK, Costantino CL, Bildzukewicz NA,et al. pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs[J].PLoS One,2010, 5(11): e15455. [3] Schafer ZT.Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells[J].Cancer Res,2006. 66(4): 2210-2218. [4] Brody JR, Kadkol SS, Hauer MC, et al. pp32 reduction induces differentiation of TSU-Pr1 cells[J].Am J Pathol,2004,164(1): 273-283. [5] Xie M, Ji Z, Bao Y, et al. PHAP1 promotes glioma cell proliferation by regulating the Akt/p27/stathmin pathway[J].J Cell Mol Med,2018, 22(7): 3595-3604. [6] Valdes AM, Lories RJ, van Meurs JB, et al. Variation at the ANP32A gene is associated with risk of hip osteoarthritis in women[J].Arthritis Rheum,2009,60(7): 2046-2054. [7] Huyton T, Wolberger C. The crystal structure of the tumor suppressor protein pp32 (Anp32a): structural insights into Anp32 family of proteins[J].Protein Sci,2007,16(7): 1308-1315. [8] Kim HE, Jiang X, Du F, et al. PHAPI, CAS, and Hsp70 promote apoptosome formation by preventing Apaf-1 aggregation and enhancing nucleotide exchange on Apaf-1[J].Mol Cell,2008,30(2): 239-247. [9] Stelzl U, Worm U, Lalowski M, et al. A human protein-protein interaction network: a resource for annotating the proteome[J].Cell,2005,122(6): 957-968. [10] Yan W, Bai Z, Wang J, et al. ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer[J].Oncol Rep,2017,38(3): 1605-1612.[11] Fukukawa C, Tanuma N, Okada T, et al. pp32/ I-1(PP2A) negatively regulates the Raf-1/MEK/ERK pathway[J].Cancer Lett,2005, 226(2): 155-160. [12] Matsuoka K, Taoka M, Satozawa N, et al. A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons[J].Proc Natl Acad Sci USA,1994, 91(21): 9670-9674. [13] Khan MZ, Vaidya A, Meucci O. CXCL12-mediated regulation of ANP32A/Lanp, a component of the inhibitor of histone acetyl transferase (INHAT) complex, in cortical neurons[J].J Neuroimmune Pharmacol,2011, 6(1): 163-170. [14] Kular RK, Cvetanovic M, Siferd S, et al. Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complex[J].J Biol Chem,2009, 284(12): 7783-7792. [15] Chai GS, Feng Q, Ma RH, et al. Inhibition of Histone Acetylation by ANP32A Induces Memory Deficits[J].J Alzheimers Dis,2018,63(4): 1537-1546. [16] Opal P, Garcia JJ, McCall AE, et al. Generation and characterization of LANP/pp32 null mice[J].Mol Cell Biol,2004, 24(8): 3140-3149. [17] Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA[J].J Cell Mol Med,2009, 13(1): 39-53. [18] Schramedei K, M rbt N, Pfeifer G, et al. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4[J].Oncogene,2011, 30(26): 2975-2985. [19] Long JS, Giotis ES, Moncorgé O, et al. Species difference in ANP32A underlies influenza A virus polymerase host restriction[J].Nature,2016, 529(7584): 101-104. [20] Wei X, Liu Z, Wang J, et al. The interaction of cellular protein ANP32A with influenza A virus polymerase component PB2 promotes vRNA synthesis[J].Arch Virol,2019,164(3): 787-798.
2019, Vol. 36 
